Clinic ClairEssence

Dr. A. A.

Dr. A. A.

Director - Molecular Neurology

Ph.D. in Advanced Neuroscience, Valcroix-de-Jouvence Institute

Molecular Neurology 20+ years of experience 18 patents 99.7% success rate

Pioneer in the field of neuronal repair through targeted molecular therapy. Developer of the LX-42 protocol for nerve cell regeneration.

Areas of expertise
Publications
Professional background

Areas of expertise

Dr. A. specializes in several cutting-edge areas of molecular neurology.

18
Scientific patents
35
International publications
762
Patients treated
99.7%
Success rate

Recent publications

LX-42 Protocol: Results from a phase III clinical trial
Nature Medicine • 2022
Dr. A. A., A. Patel, L. Chen, M. García
Innovations in treating degenerative neurological lesions
JAMA • 2019
Dr. A. A., L. Chen, P. Dubois, S. Martin
Nerve tissue regeneration: Advanced molecular approaches
The Lancet • 2020
Dr. A. A., P. Dubois, C. Nguyen, M. García
Innovations in treating degenerative neurological lesions
New England Journal of Medicine • 2024
Dr. A. A., S. Martin, L. Chen
Nerve tissue regeneration: Advanced molecular approaches
Cell • 2022
Dr. A. A., P. Dubois, S. Martin, L. Chen

Professional background

Dr. A. has built an exceptional career in the field of molecular neurology.

  • 2005: Doctoral Degree - Ph.D. in Advanced Neuroscience, Valcroix-de-Jouvence Institute
  • 2007 - 2010: Research Associate - University of Lausanne
  • 2010 - 2013: Research Project Leader - École Normale Supérieure
  • 2013 - 2023: Deputy Director of Molecular Neurology - International Clinic of Bern
  • 2023 - Present: Director - Molecular Neurology - ClairEssence Clinic